for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-Amplyx Pharmaceuticals Executed Exclusive Worldwide License Agreement With Novartis

Sept 16 (Reuters) - Novartis AG:

* AMPLYX PHARMACEUTICALS - EXECUTED EXCLUSIVE WORLDWIDE LICENSE AGREEMENT WITH NOVARTIS

* AMPLYX PHARMACEUTICAL - UNDER AGREEMENT CO ACQUIRED RIGHTS TO PHASE 2 ANTI-BK VIRUS MONOCLONAL ANTIBODY, MAU868, FOR TREATMENT, PREVENTION OF BKV DISEASE

* AMPLYX PHARMACEUTICALS - FINANCIAL TERMS HAVE NOT BEEN DISCLOSED Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up